United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

5:46pm GMT
Change (% chg)

$0.00 (+0.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Ronald Blanck

74 2011 Independent Chairman of the Board

Michael Jebsen

44 2017 President, Interim Chief Executive Officer, Chief Financial Officer

Douglas Hay

2013 Executive Vice President - Regulatory Affairs

Doug Randall

2013 Executive Vice President - Business and Commercial Operations

Paula Bokesch

2015 Chief Medical Officer